|
1
|
Abdel-Moneim A, Bakery HH and Allam G: The
potential pathogenic role of IL-17/Th17 cells in both type 1 and
type 2 diabetes mellitus. Biomed Pharmacother. 101:287–292. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koro CE, Bowlin SJ, Bourgeois N and Fedder
DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed
with type 2 diabetes: A preliminary report. Diabetes care.
27:17–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Badri N and Ghoneim MA: Mesenchymal
stem cell therapy in diabetes mellitus: Progress and challenges. J
Nucleic Acids. 2013:1948582013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS,
Toth E, Warnock GL, Kneteman NM and Rajotte RV: Islet
transplantation in seven patients with type 1 diabetes mellitus
using a glucocorticoid-free immunosuppressive regimen. N Engl J
Med. 343:230–238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barton FB, Rickels MR, Alejandro R, Hering
BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR,
Levy M, et al: Improvement in outcomes of clinical islet
transplantation: 1999–2010. Diabetes Care. 35:1436–1445. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ricordi C: Islet transplantation: A brave
new world. Diabetes. 52:1595–1603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brandhorst H, Asif S, Andersson K, Mönch
J, Friedrich O, Rämsch-Günther N, Rämsch C, Steffens M, Lambrecht
J, Schräder T, et al: The effect of truncated collagenase class I
isomers on human islet isolation outcome. Transplantation.
90:334–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito T, Itakura S, Todorov I, Rawson J,
Asari S, Shintaku J, Nair I, Ferreri K, Kandeel F and Mullen Y:
Mesenchymal stem cell and islet co-transplantation promotes graft
revascularization and function. Transplantation. 89:1438–1445.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rackham CL, Chagastelles PC, Nardi NB,
Hauge-Evans AC, Jones PM and King AJ: Co-transplantation of
mesenchymal stem cells maintains islet organisation and morphology
in mice. Diabetologia. 54:1127–1135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Perez-Basterrechea M, Obaya AJ, Meana A,
Otero J and Esteban MM: Cooperation by fibroblasts and bone
marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse
islet xenotransplantation. PLoS One. 8:e735262013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berman DM, Willman MA, Han D, Kleiner G,
Kenyon NM, Cabrera O, Karl JA, Wiseman RW, O'Connor DH, Bartholomew
AM and Kenyon NS: Mesenchymal stem cells enhance allogeneic islet
engraftment in nonhuman primates. Diabetes. 59:2558–2568. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakata N, Goto M, Yoshimatsu G, Egawa S
and Unno M: Utility of co-transplanting mesenchymal stem cells in
islet transplantation. World J Gastroenterol. 17:5150–5155. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sordi V, Melzi R, Mercalli A, Formicola R,
Doglioni C, Tiboni F, Ferrari G, Nano R, Chwalek K, Lammert E, et
al: Mesenchymal cells appearing in pancreatic tissue culture are
bone marrow-derived stem cells with the capacity to improve
transplanted islet function. Stem Cells. 28:140–151. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Golocheikine A, Tiriveedhi V, Angaswamy N,
Benshoff N, Sabarinathan R and Mohanakumar T: Cooperative signaling
for angiogenesis and neovascularization by VEGF and HGF following
islet transplantation. Transplantation. 90:725–731. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding Y, Xu D, Feng G, Bushell A, Muschel
RJ and Wood KJ: Mesenchymal stem cells prevent the rejection of
fully allogenic islet grafts by the immunosuppressive activity of
matrix metalloproteinase-2 and −9. Diabetes. 58:1797–1806. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karaoz E, Genc ZS, Demircan PC, Aksoy A
and Duruksu G: Protection of rat pancreatic islet function and
viability by coculture with rat bone marrow-derived mesenchymal
stem cells. Cell Death Dis. 1:e362010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie QP, Huang H, Xu B, Dong X, Gao SL,
Zhang B and Wu YL: Human bone marrow mesenchymal stem cells
differentiate into insulin-producing cells upon microenvironmental
manipulation in vitro. Differentiation. 77:483–491. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grayson WL, Zhao F, Izadpanah R, Bunnell B
and Ma T: Effects of hypoxia on human mesenchymal stem cell
expansion and plasticity in 3D constructs. J Cell Physiol.
207:331–339. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosova I, Dao M, Capoccia B, Link D and
Nolta JA: Hypoxic preconditioning results in increased motility and
improved therapeutic potential of human mesenchymal stem cells.
Stem Cells. 26:2173–2182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hung SC, Pochampally RR, Chen SC, Hsu SC
and Prockop DJ: Angiogenic effects of human multipotent stromal
cell conditioned medium activate the PI3K-Akt pathway in hypoxic
endothelial cells to inhibit apoptosis, increase survival and
stimulate angiogenesis. Stem Cells. 25:2363–2370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dao MA, Pepper KA and Nolta JA: Long-term
cytokine production from engineered primary human stromal cells
influences human hematopoiesis in an in vivo xenograft model. Stem
cells. 15:443–454. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Amato F, Noli B, Brancia C, Cocco C,
Flore G, Collu M, Nicolussi P and Ferri GL: Differential
distribution of VGF-derived peptides in the adrenal medulla and
evidence for their selective modulation. J Endocrinol. 197:359–369.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ichii H, Wang X, Messinger S, Alvarez A,
Fraker C, Khan A, Kuroda Y, Inverardi L, Goss JA, Alejandro R and
Ricordi C: Improved human islet isolation using nicotinamide. Am J
Transplant. 6:2060–2068. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo JZ, Xiong F, Al-Homsi AS, Roy T and
Luo LG: Human BM stem cells initiate angiogenesis in human islets
in vitro. Bone Marrow Transplantat. 46:1128–1137. 2011. View Article : Google Scholar
|
|
28
|
Hajizadeh-Saffar E, Tahamtani Y, Aghdami
N, Azadmanesh K, Habibi-Anbouhi M, Heremans Y, De Leu N, Heimberg
H, Ravassard P, Shokrgozar MA and Baharvand H: Inducible VEGF
expression by human embryonic stem cell-derived mesenchymal stromal
cells reduces the minimal islet mass required to reverse diabetes.
Sci Rep. 5:93222015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato Y, Endo H, Okuyama H, Takeda T,
Iwahashi H, Imagawa A, Yamagata K, Shimomura I and Inoue M:
Cellular hypoxia of pancreatic beta-cells due to high levels of
oxygen consumption for insulin secretion in vitro. J Biol Chem.
286:12524–12532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Buchwald P: A local glucose-and oxygen
concentration-based insulin secretion model for pancreatic islets.
Theor Biol Med Model. 8:202011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Espes D, Lau J, Quach M, Banerjee U,
Palmer AF and Carlsson PO: Cotransplantation of Polymerized
Hemoglobin Reduces β-Cell Hypoxia and Improves β-Cell Function in
Intramuscular Islet Grafts. Transplantation. 99:2077–2082. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liljeback H, Grapensparr L, Olerud J and
Carlsson PO: Extensive loss of islet mass beyond the first day
after intraportal human islet transplantation in a mouse model.
Cell Transplant. 25:481–489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiao N, Xu C, Zhu YX, Cao Y, Liu DC and
Han X: Ets-1 as an early response gene against hypoxia-induced
apoptosis in pancreatic β-cells. Cell Death Dis. 6:e16502015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gerber PA, Bellomo EA, Hodson DJ, Meur G,
Solomou A, Mitchell RK, Hollinshead M, Chimienti F, Bosco D, Hughes
SJ, et al: Hypoxia lowers SLC30A8/ZnT8 expression and free
cytosolic Zn2+ in pancreatic beta cells. Diabetologia.
57:1635–1644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sakata N, Chan NK, Chrisler J, Obenaus A
and Hathout E: Bone marrow cell cotransplantation with islets
improves their vascularization and function. Transplantation.
89:686–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lampert FM, Kutscher C, Stark GB and
Finkenzeller G: Overexpression of Hif-1α in mesenchymal stem cells
affects cell-autonomous angiogenic and osteogenic parameters. J
Cell Biochem. 117:760–768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao D, Zhu M, Zhang X, Ma R, Yang X, Ke T,
Wang L, Li Z, Kong D and Li C: A macroporous heparin-releasing silk
fibroin scaffold improves islet transplantation outcome by
promoting islet revascularisation and survival. Acta Biomater.
59:210–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Linnemann AK, Blumer J, Marasco MR,
Battiola TJ, Umhoefer HM, Han JY, Lamming DW and Davis DB:
Interleukin 6 protects pancreatic beta cells from apoptosis by
stimulation of autophagy. FASEB J. 31:4140–4152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Melzi R, Mercalli A, Sordi V, Cantarelli
E, Nano R, Maffi P, Sitia G, Guidotti LG, Secchi A, Bonifacio E and
Piemonti L: Role of CCL2/MCP-1 in islet transplantation. Cell
Transplant. 19:1031–1046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meier DT, Tu LH, Zraika S, Hogan MF,
Templin AT, Hull RL, Raleigh DP and Kahn SE: Matrix
metalloproteinase-9 protects islets from amyloid-induced toxicity.
J Biol Chem. 290:30475–30485. 2015. View Article : Google Scholar : PubMed/NCBI
|
